Skip to main content

Table 3 Sample size calculation for repeated measures design

From: An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home

Sample size calculation for repeated measures design

 

Standard deviation (drawn from literature review)

7.64

Estimated minimal important difference (effect size)

2

Target power (1-β error probability)

.80

Target alpha

.05

Estimated required size per treatment arm

32

Estimated minimum sample size for two arms

64

Target recruitment size (accounting for 30% attrition)

80